Transcriptomic analysis reveals a previously unknown role for CD8+ T-cells in rVSV-EBOV mediated protection
Abstract Ebola virus (EBOV) poses a significant threat to human health as highlighted by the recent epidemic in West Africa. Data from animal studies and a ring vaccination clinical trial conducted in Guinea during the recent epidemic demonstrated that a recombinant VSV where G protein is replaced w...
Main Authors: | Andrea R. Menicucci, Suhas Sureshchandra, Andrea Marzi, Heinz Feldmann, Ilhem Messaoudi |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2017-04-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-017-01032-8 |
Similar Items
-
Antiviral Innate Responses Induced by VSV-EBOV Vaccination Contribute to Rapid Protection
by: Andrea R. Menicucci, et al.
Published: (2019-05-01) -
To B or Not to B: Mechanisms of Protection Conferred by rVSV-EBOV-GP and the Roles of Innate and Adaptive Immunity
by: Amanda N. Pinski, et al.
Published: (2020-09-01) -
Single low-dose VSV-EBOV vaccination protects cynomolgus macaques from lethal Ebola challenge
by: Andrea Marzi, et al.
Published: (2019-11-01) -
Titration methods for rVSV-based vaccine manufacturing
by: Jean-François Gélinas, et al.
Published: (2020-01-01) -
Protection Against Marburg Virus Using a Recombinant VSV-Vaccine Depends on T and B Cell Activation
by: Andrea Marzi, et al.
Published: (2019-01-01)